文献速递瓣膜病与结构性心脏病

清醒镇静与全身麻醉在经导管主动脉瓣置换术中的比较:来自NCDR STS/ACC TVT注册研究

Conscious Sedation Versus General Anesthesia for Transcatheter Aortic Valve Replacement: Insights from the National Cardiovascular Data Registry Society of Thoracic Surgeons/American College of Cardiology Transcatheter Valve Therapy Registry.
PubMed 文献 · Circulation · 2017-09-01

基于美国NCDR STS/ACC TVT注册研究,分析2014年4月至2015年6月所有择期经股动脉TAVR患者,比较清醒镇静与全身麻醉的临床结局。清醒镇静使用率为15.8%且呈上升趋势。倾向加权调整后,清醒镇静与较低的院内死亡率(1.5% vs 2.4%)、30天死亡率(2.3% vs 4.0%)、30天死亡/卒中复合率(4.8% vs 6.4%)及更短的住院时间(6.0 vs 6.5天)相关,但程序成功率略低(97.9% vs 98.6%)。

要点

  • 清醒镇静用于TAVR的比例为15.8%且逐年增加。
  • 调整后清醒镇静与更低的院内和30天死亡率相关。
  • 清醒镇静组住院时间更短,但程序成功率略低。

核心结论

  • 在美国实践中,与全身麻醉相比,清醒镇静TAVR与更短的住院时间和更低的院内及30天死亡率相关,但观察性数据不能确定一种技术优于另一种。

主要发现

  • 未调整分析中,清醒镇静组院内死亡率1.6% vs 2.5%(P=0.03),30天死亡率2.9% vs 4.1%(P=0.03),程序成功率98.2% vs 98.5%(P=0.31)。
  • 清醒镇静转全身麻醉的比例为102/1737(5.9%)。
  • 加权调整后,清醒镇静组程序成功率97.9% vs 98.6%(P<0.001),院内死亡率1.5% vs 2.4%(P<0.001),30天死亡率2.3% vs 4.0%(P<0.001),30天死亡/卒中复合率4.8% vs 6.4%(P<0.001),住院时间6.0 vs 6.5天(P<0.001)。
  • 伪造终点分析显示血管并发症、出血和新起搏器/除颤器植入在调整后无显著差异。

关键数值与推荐

  • 清醒镇静组程序成功率97.9%,全身麻醉组98.6%(P<0.001)。
  • 清醒镇静组院内死亡率1.5%,全身麻醉组2.4%(P<0.001)。
  • 清醒镇静组30天死亡率2.3%,全身麻醉组4.0%(P<0.001)。
  • 清醒镇静组30天死亡/卒中复合率4.8%,全身麻醉组6.4%(P<0.001)。
  • 清醒镇静组住院时间6.0天,全身麻醉组6.5天(P<0.001)。

临床怎么用

  • 对于择期经股动脉TAVR患者,清醒镇静可作为全身麻醉的替代选择,与更短的住院时间和更低的短期死亡率相关。
  • 需注意清醒镇静有5.9%的转全身麻醉率,应做好中转准备。

局限性

  • 观察性比较有效性分析不能 definitively 确定一种技术优于另一种。
  • 原文未报告其他局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Conscious sedation is used during transcatheter aortic valve replacement (TAVR) with limited evidence as to the safety and efficacy of this practice. METHODS: The National Cardiovascular Data Registry Society of Thoracic Surgeons/American College of Cardiology Transcatheter Valve Therapy Registry was used to characterize the anesthesia choice and clinical outcomes of all US patients undergoing elective percutaneous transfemoral TAVR between April 1, 2014, and June 30, 2015. Raw and inverse probability of treatment-weighted analyses were performed to compare patients undergoing TAVR with general anesthesia with patients undergoing TAVR with conscious sedation on an intention-to-treat basis for the primary outcome of in-hospital mortality, and secondary outcomes including 30-day mortality, in-hospital and 30-day death/stroke, procedural success, intensive care unit and hospital length-of-stay, and rates of discharge to home. Post hoc falsification end point analyses were performed to evaluate for residual confounding. RESULTS: Conscious sedation was used in 1737/10 997 (15.8%) cases with a significant trend of increasing usage over the time period studied (P for trend<0.001). In raw analyses, intraprocedural success with conscious sedation and general anesthesia was similar (98.2% versus 98.5%, P=0.31). The conscious sedation group was less likely to experience in-hospital (1.6% versus 2.5%, P=0.03) and 30-day death (2.9% versus 4.1%, P=0.03). Conversion from conscious sedation to general anesthesia was noted in 102 of 1737 (5.9%) of conscious sedation cases. After inverse probability of treatment-weighted adjustment for 51 covariates, conscious sedation was associated with lower procedural success (97.9% versus 98.6%, P<0.001) and a reduced rate of mortality at the in-hospital (1.5% versus 2.4%, P<0.001) and 30-day (2.3% versus 4.0%, P<0.001) time points. Conscious sedation was associated with reductions in procedural inotrope requirement, intensive care unit and hospital length of stay (6.0 versus 6.5 days, P<0.001), and combined 30-day death/stroke rates (4.8% versus 6.4%, P<0.001). Falsification end point analyses of vascular complications, bleeding, and new pacemaker/defibrillator implantation demonstrated no significant differences between groups after adjustment. CONCLUSIONS: In US practice, conscious sedation is associated with briefer length of stay and lower in-hospital and 30-day mortality in comparison with TAVR with general anesthesia in both unadjusted and adjusted analyses. These results suggest the safety of conscious sedation in this population, although comparative effectiveness analyses using observational data cannot definitively establish the superiority of one technique over another.

来源:Circulation,查看原文。版权归原作者所有。

引用

  1. Hyman MC, Vemulapalli S, Szeto WY, et al. Conscious Sedation Versus General Anesthesia for Transcatheter Aortic Valve Replacement: Insights from the National Cardiovascular Data Registry Society of Thoracic Surgeons/American College of Cardiology Transcatheter Valve Therapy Registry. Circulation. 2017. PMID: 28864443. doi:10.1161/CIRCULATIONAHA.116.026656

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。